Resilux NV
Resilux NV Fundamental Analysis
Resilux NV (RES.BR) shows weak financial fundamentals with a PE ratio of 18.04, profit margin of 6.03%, and ROE of 15.10%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze RES.BR's fundamental strength across five key dimensions:
Efficiency Score
WeakRES.BR struggles to generate sufficient returns from assets.
Valuation Score
ExcellentRES.BR trades at attractive valuation levels.
Growth Score
ModerateRES.BR shows steady but slowing expansion.
Financial Health Score
ExcellentRES.BR maintains a strong and stable balance sheet.
Profitability Score
WeakRES.BR struggles to sustain strong margins.
Key Financial Metrics
Is RES.BR Expensive or Cheap?
P/E Ratio
RES.BR trades at 18.04 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, RES.BR's PEG of 0.18 indicates potential undervaluation.
Price to Book
The market values Resilux NV at 2.53 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.24 times EBITDA. This is generally considered low.
How Well Does RES.BR Make Money?
Net Profit Margin
For every $100 in sales, Resilux NV keeps $6.03 as profit after all expenses.
Operating Margin
Core operations generate 8.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.10 in profit for every $100 of shareholder equity.
ROA
Resilux NV generates $8.31 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $7.15 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.04
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.18
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.53
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.13
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.53
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How RES.BR Stacks Against Its Sector Peers
| Metric | RES.BR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.04 | 23.78 | Better (Cheaper) |
| ROE | 15.10% | 1098.00% | Weak |
| Net Margin | 6.03% | -626.00% (disorted) | Weak |
| Debt/Equity | 0.13 | 0.86 | Strong (Low Leverage) |
| Current Ratio | 1.53 | 2.64 | Neutral |
| ROA | 8.31% | -8081.00% (disorted) | Weak |
RES.BR outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Resilux NV's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
EPS CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
FCF CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary